Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEG-IFN alfa-2a dose and duration factorial study in adults with HBeAg-positive chronic hepatitis B
2006-000870-63Phase 4Completed
- Sponsor
- Roche
- Start
- Jan 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of peginterferon alfa-2a in Chronic Hepatitis B (CHB) (4 arms), sponsored by Roche. Started Jan 2007; status: completed.
02
Drugs
peginterferon alfa-2a
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on 2006-000870-63.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000870-63.